Former Vifor Pharma CEO had no knowledge of alleged Pharmacosmos smear campaign

In the years 2014–2016, Søren Tulstrup served as the chief executive of Vifor Pharma, which is now at the center of an antitrust investigation led by the EU Commission.
Søren Tulstrup previously served as CEO of Vifor Pharma, and is currently the CEO of Hansa Biopharma | Photo: Hansa Biopharma
Søren Tulstrup previously served as CEO of Vifor Pharma, and is currently the CEO of Hansa Biopharma | Photo: Hansa Biopharma
by christian bundgaard, translated by daniel pedersen

”I did not know of any campaign back when I was leading Vifor. Monofer was obviously a product we were competing against, but there wasn’t any campaign at that point,” responds Søren Tulstrup when asked about EU Commission’s recently initiated antitrust investigation into the firm he used to spearhead.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading